# Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers

> **NCT02044367** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dabigatran etexilate
- **DRUG:** Dabigatran etexilate
- **DRUG:** Dabigatran etexilate

## Key facts

- **NCT ID:** NCT02044367
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044367, "Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02044367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*